MyMD Pharmaceuticals Inc (MYMD)
3.33
+0.08
(+2.46%)
USD |
NASDAQ |
May 03, 16:00
3.12
-0.21
(-6.31%)
After-Hours: 20:00
MyMD Pharmaceuticals Price to Book Value: 0.5877 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 0.5877 |
| May 02, 2024 | 0.5736 |
| May 01, 2024 | 0.5648 |
| April 30, 2024 | 0.5436 |
| April 29, 2024 | 0.5118 |
| April 26, 2024 | 0.5012 |
| April 25, 2024 | 0.4959 |
| April 24, 2024 | 0.5048 |
| April 23, 2024 | 0.4518 |
| April 22, 2024 | 0.4553 |
| April 19, 2024 | 0.4412 |
| April 18, 2024 | 0.4447 |
| April 17, 2024 | 0.3971 |
| April 16, 2024 | 0.3706 |
| April 15, 2024 | 0.4006 |
| April 12, 2024 | 0.4236 |
| April 11, 2024 | 0.4412 |
| April 10, 2024 | 0.4853 |
| April 09, 2024 | 0.4624 |
| April 08, 2024 | 0.4536 |
| April 05, 2024 | 0.3706 |
| April 04, 2024 | 0.3848 |
| April 03, 2024 | 0.3971 |
| April 02, 2024 | 0.3918 |
| April 01, 2024 | 0.4006 |
| Date | Value |
|---|---|
| March 28, 2024 | 0.4089 |
| March 27, 2024 | 0.4021 |
| March 26, 2024 | 0.3952 |
| March 25, 2024 | 0.4209 |
| March 22, 2024 | 0.4534 |
| March 21, 2024 | 0.491 |
| March 20, 2024 | 0.4893 |
| March 19, 2024 | 0.4927 |
| March 18, 2024 | 0.4859 |
| March 15, 2024 | 0.4927 |
| March 14, 2024 | 0.5304 |
| March 13, 2024 | 0.5509 |
| March 12, 2024 | 0.5389 |
| March 11, 2024 | 0.604 |
| March 08, 2024 | 0.5458 |
| March 07, 2024 | 0.5406 |
| March 06, 2024 | 0.5236 |
| March 05, 2024 | 0.5475 |
| March 04, 2024 | 0.556 |
| March 01, 2024 | 0.5697 |
| February 29, 2024 | 0.5868 |
| February 28, 2024 | 0.556 |
| February 27, 2024 | 0.5886 |
| February 26, 2024 | 0.592 |
| February 23, 2024 | 0.5783 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3706
Minimum
Apr 05 2024
14.08
Maximum
Nov 01 2021
5.353
Average
5.275
Median
Nov 04 2022
Price to Book Value Benchmarks
| Acrivon Therapeutics Inc | 2.443 |
| Vincerx Pharma Inc | 1.674 |
| CEL-SCI Corp | 6.955 |
| AIM ImmunoTech Inc | 2.116 |
| IGC Pharma Inc | 3.599 |
Price to Book Value Related Metrics
| Price | 3.33 |
| Earnings Yield | -169.1% |
| Market Cap | 7.185M |